CClinicalTrials.gg
Status unknownNCT04801251Updated Sep 14, 2021

Red Flags for Cardiac Examination for Early Detection of Congenital Heart Disease

An interventional study of Echocardiographic examination in Congenital Heart Disease, sponsored by Assiut University. Status unknown. Open to participants aged 1 Day to 28 Days, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-09-14.

Sponsored by Assiut University · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Sep 2021), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
1 Day to 28 Days
Sex
All
01

Study summary

The study done to identify the relation between the presence of abnormal clinical cardiac findings and the echocardiographic findings in newborn infants.

Read the detailed description

A full history will be taken, complete general systemic and cardiac examination will be done. All patients with abnormal physical cardiac examination in the neonatal period (≤ 28 days of age) according to the inclusion criteria will have echocardiographic examination.

02

Conditions studied

  • Congenital Heart Disease
03

In context

Heart Diseases

3,639 studies on the registry are indexed under Heart Diseases; 461 are open to participants now.

This study's planned enrollment of 70 is below the median of 100 across 1,779 interventional studies indexed under Heart Diseases.

Browse Heart Diseases studies →

Lead sponsor

Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Day to 28 Days
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

    • Abnormal heart rate (\< 90/min or \< 160 per min )

      • Comfortable tachypnea ( RR > 60/min without other manifestations of respiratory distress)
      • Abnormal heart sounds (muffled, accentuated, single )
      • Abnormal precordial activity
      • Murmur: ( ≥ grade 3 intenisty, holosystolic timing, maximum intensity at upper left sternal border or with upright positing, diastolic murmur, harsh or blowing quality )
      • Abnormal oxygen saturation \<90% in any extremity Oxygen saturation gradient > 3% difference in extremities.
      • Blood pressure gradient >10 mmHg higher in arms >10 mmHg lower in legs
      • Abnormal femoral pulses
      • Weakened pulses
      • Absent pulses
      • Hepatomegaly
      • Family history of cardiac disease

Exclusion criteria

Exclusion Criteria:

  • Newborns with disorders affecting the heart as anemia, septicemia, respiratory disorders as respiratory distress syndrome, pneumonia, hypoplastic lung, renal impairment, hypertension, metabolic disease, syndromatic CHF
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
70 participants (estimated)

Study arms

  • Other
    Resident

    Full history.complete systemic and cardiac physical examination

    Diagnostic Test: Echocardiographic examination

  • Other
    Assistant Lecturer

    Echocardiographic examination

    Diagnostic Test: Echocardiographic examination

Interventions

  • Diagnostic testEchocardiographic examination

    Each patient included will undergo full cardiac physical examination and echocardiographic examination

    Also known as: Full physical and cardiac examination

06

What researchers measure

Primary outcomes

  1. Red flags for cardiac examination

    A complete general systemic and cardiac examination will be done. All patients with abnormal physical cardiac examination in the neonatal period (≤ 28 days of age) according to the inclusion criteria will have echocardiographic examination. Methods: 1. Echocardiogram reports will be reviewed and cardiovascular abnormalities will be noted. The presence of patent ductus arteriosus (PDA) will be considered a normal finding if present at ≤ 7 days of age but not beyond. A patent foramen ovale will be considered normal. A small muscular ventricular septal defect (VSD), although common in neonates and, will be considered an abnormal finding. 2. All patients will have pulse oximeter screening, newborns with pulse oximetry ≥ 95% in the right hand or foot and ≤ 3% difference between the right hand and either foot at any time of testing have a normal result, and require no further testing.

    Time frame: 1 year

  2. The importance of history in detecting congenital heart disease

    A full history will be taken, family history of congenital heart disease, mother's age and consanguinity, gravidity and parity should also be included. A File will be prepared for each neonate, which consist of demographic details including cardiac physical examination findings, birth weight, fetal age, history of folic acid intake by the mother, family history of cardiac disease, pulse oximeter screening, and results will be recorded. Data will be collected in form of taking history by interviewing questionnaire and full clinical examination will be done particularly cardiac examination and all findings will be recorded in patient clinical checklist. X\^2 will be used to compare frequencies among different categories. Student T test, ANOVA will be used to test differences between means. ALL statistical analysis will be performed by using the SPSS version 20. P value \<0.05 will be considered statistically significant for all applied statistical tests.

    Time frame: 1 year

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Chitra N, Vijayalakshmi IB. Fetal echocardiography for early detection of congenital heart diseases. J Echocardiogr. 2017 Mar;15(1):13-17. doi: 10.1007/s12574-016-0308-2. Epub 2016 Aug 16. PubMed 27530200 ↗
  • Hiremath G, Kamat D. When to call the cardiologist: treatment approaches to neonatal heart murmur. Pediatr Ann. 2013 Aug;42(8):329-33. doi: 10.3928/00904481-20130723-13. No abstract available. PubMed 23910039 ↗
  • Triedman JK, Newburger JW. Trends in Congenital Heart Disease: The Next Decade. Circulation. 2016 Jun 21;133(25):2716-33. doi: 10.1161/CIRCULATIONAHA.116.023544. No abstract available. PubMed 27324366 ↗

Individual participant data

Plan to share: Yes — A full history will be taken, complete general systemic and cardiac examination will be done. All patients with abnormal physical cardiac examination in the neonatal period (≤ 28 days of age) according to the inclusion criteria will have echocardiographic examination.

Supporting information: Study protocol, Sap, Icf, Csr

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 14, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04801251
Lead sponsor
Assiut University
Responsible party
Sarah Bakry Gaber Ahmed (Assistant Lecturer, Assiut University) — Principal investigator
First posted
Mar 16, 2021
Start date
Oct 20, 2021 (estimated)
Primary completion
Oct 20, 2022 (estimated)
Completion
Dec 20, 2022 (estimated)
Last update
Sep 14, 2021

Study contacts

Sarah Bakry, Resident
Contact
Sarabakry94@gmail.com
01129324744
Amira Shalaby, Lecturer
Contact
amirashalaby@aun.edu.eg
01223958949
Nagwa Ali, Professor
study director · Assiut University
Amira Shalaby, Lecturer
study director · Assiut University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion